Search
 

Pfizer Takes 105,000 SF in Mission Bay Project

SAN FRANCISCO-The world's largest drugmaker will relocate its Biotherapeutics and Bioinnovation Center from South San Francisco in early 2010.

By Brian K. Miller | Updated on August 05, 2008

SAN FRANCISCO-Publicly held drugmaker Pfizer Inc. has leased 105,000 sf of office and laboratory space in a new Mission Bay building for its Biotherapeutics and Bioinnovation Center. A source with Pfizer tells GlobeSt.com the company signed a long-term lease for the upper floors of the five-story building’s west wing, and was checking to confirm that the company also retains an option to lease an additional 50,000 sf in the east wing. The center will relocate to the building upon its completion in early 2010 from a similar-sized space on East Grand Avenue in South San Francisco, according to the source.

The building Pfizer will occupy is under construction at 455 Mission Bay Blvd. S., across the street from the Mission Bay campus of the University of California at San Francisco. Pfizer and UCSF recently concluded a three-year, $9.5 million partnership designed to speed drug discovery and development between the company and the California Institute for Quantitative Biosciences, which is located a few blocks from 455 Mission Bay.

The Mission Bay area is a 303-acre area that previously housed a landfill, rail yard and warehouses. It is now a burgeoning biotech hub. Merk & Co. leases 66,000 sf at 1700 Owens St, which also is owned by ARE, and FibroGen is close to occupying its half of a 430,000-sf Shorenstein development at 16th and Illinois streets, and has an option for the other half.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.